Pharmacopeial Specifications:
-
Iron Content: 15–25%
-
Ascorbic Acid Content: 35–45%
-
Identification: Positive for iron and ascorbate
-
Loss on Drying: ≤5%
-
pH (1% solution): 3.0–5.0
-
Microbial Limits: Complies with pharmacopeial requirements
Applications in Pharmaceutical Formulation:
Commonly used in oral iron supplements such as tablets and syrups to treat iron deficiency anemia. Ascorbic acid improves the bioavailability of iron and prevents its oxidation.
Comments:
Ferrous ascorbate combines high iron bioavailability with the antioxidant benefits of vitamin C. It is more stable than traditional iron salts in solution and exhibits fewer oxidative interactions with excipients in formulation.
